ID   MIA3_HUMAN              Reviewed;        1907 AA.
AC   Q5JRA6; A8K2S0; A8MT05; A8MT13; B7Z430; Q14083; Q3S4X3; Q5JRA5;
AC   Q5JRB0; Q5JRB1; Q5JRB2; Q6UVY8; Q86Y60; Q8N8M5; Q92580;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   10-MAY-2017, entry version 117.
DE   RecName: Full=Melanoma inhibitory activity protein 3;
DE   AltName: Full=C219-reactive peptide;
DE   AltName: Full=D320;
DE   AltName: Full=Transport and Golgi organization protein 1;
DE   Flags: Precursor;
GN   Name=MIA3; Synonyms=KIAA0268, TANGO, TANGO1;
GN   ORFNames=UNQ6077/PRO20088;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   GLU-482.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 419-1492 (ISOFORM 2).
RC   TISSUE=Brain, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-125, AND TISSUE SPECIFICITY.
RX   PubMed=15183315; DOI=10.1016/j.modgep.2003.12.002;
RA   Bosserhoff A.K., Moser M., Buettner R.;
RT   "Characterization and expression pattern of the novel MIA homolog
RT   TANGO.";
RL   Gene Expr. Patterns 4:473-479(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 715-1907 (ISOFORM 1), AND
RP   VARIANT GLY-881.
RC   TISSUE=Bone marrow;
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI.
RT   The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by
RT   analysis of cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1306-1441.
RC   TISSUE=Leukemia;
RX   PubMed=7758977; DOI=10.1016/0378-1119(94)00541-Y;
RA   Norris M.D., Gilbert J., Madafiglio J., Haber M.;
RT   "Analysis of a novel cDNA encoding a C219-reactive peptide isolated
RT   from methotrexate-selected multidrug-resistant human leukemic cells.";
RL   Gene 156:313-314(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1441-1907 (ISOFORM 1), AND
RP   VARIANTS CYS-1659 AND GLU-1723.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=17044017; DOI=10.1002/ijc.22242;
RA   Arndt S., Bosserhoff A.K.;
RT   "TANGO is a tumor suppressor of malignant melanoma.";
RL   Int. J. Cancer 119:2812-2820(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1906, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH COL7A1, TOPOLOGY, AND
RP   DOMAIN.
RX   PubMed=19269366; DOI=10.1016/j.cell.2008.12.025;
RA   Saito K., Chen M., Bard F., Chen S., Zhou H., Woodley D.,
RA   Polischuk R., Schekman R., Malhotra V.;
RT   "TANGO1 facilitates cargo loading at endoplasmic reticulum exit
RT   sites.";
RL   Cell 136:891-902(2009).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-589.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   INTERACTION WITH CTAGE5, SUBCELLULAR LOCATION, AND REGION.
RX   PubMed=21525241; DOI=10.1091/mbc.E11-02-0143;
RA   Saito K., Yamashiro K., Ichikawa Y., Erlmann P., Kontani K.,
RA   Malhotra V., Katada T.;
RT   "cTAGE5 mediates collagen secretion through interaction with TANGO1 at
RT   endoplasmic reticulum exit sites.";
RL   Mol. Biol. Cell 22:2301-2308(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1745, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1706, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727; SER-876; SER-1067;
RP   SER-1706 AND SER-1906, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   PHOSPHORYLATION AT SER-226; SER-229 AND SER-1906.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH APOB AND MIA2.
RX   PubMed=27138255; DOI=10.1083/jcb.201603072;
RA   Santos A.J., Nogueira C., Ortega-Bellido M., Malhotra V.;
RT   "TANGO1 and Mia2/cTAGE5 (TALI) cooperate to export bulky pre-
RT   chylomicrons/VLDLs from the endoplasmic reticulum.";
RL   J. Cell Biol. 213:343-354(2016).
CC   -!- FUNCTION: Plays a role in the transport of cargos that are too
CC       large to fit into COPII-coated vesicles and require specific
CC       mechanisms to be incorporated into membrane-bound carriers and
CC       exported from the endoplasmic reticulum. This protein is required
CC       for collagen VII (COL7A1) secretion by loading COL7A1 into
CC       transport carriers. It may participate in cargo loading of COL7A1
CC       at endoplasmic reticulum exit sites by binding to COPII coat
CC       subunits Sec23/24 and guiding SH3-bound COL7A1 into a growing
CC       carrier. Does not play a role in global protein secretion and is
CC       apparently specific to COL7A1 cargo loading. However, it may
CC       participate in secretion of other proteins in cells that do not
CC       secrete COL7A1. It is also specifically required for the secretion
CC       of lipoproteins by participating in their export from the
CC       endoplasmic reticulum (PubMed:27138255).
CC       {ECO:0000269|PubMed:19269366, ECO:0000269|PubMed:27138255}.
CC   -!- SUBUNIT: Interacts (via SH3 domain) with COL7A1. Interacts with
CC       the COPII coat subunits SEC23A and SEC24C. Interacts with CTAGE5
CC       (PubMed:21525241). May interact with APOB and MIA2
CC       (PubMed:27138255). {ECO:0000269|PubMed:19269366,
CC       ECO:0000269|PubMed:21525241, ECO:0000269|PubMed:27138255}.
CC   -!- INTERACTION:
CC       D3DR37:CEP55; NbExp=4; IntAct=EBI-10244342, EBI-10173536;
CC       Q02388:COL7A1; NbExp=2; IntAct=EBI-2291868, EBI-724237;
CC       P51116:FXR2; NbExp=3; IntAct=EBI-10244342, EBI-740459;
CC       Q9GZV8:PRDM14; NbExp=3; IntAct=EBI-10244342, EBI-3957793;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-10244342, EBI-719493;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:19269366, ECO:0000269|PubMed:21525241};
CC       Single-pass membrane protein {ECO:0000269|PubMed:19269366}.
CC       Note=Localizes at endoplasmic reticulum exit sites. After loading
CC       of COL7A1 into transport carriers, it is not incorporated into
CC       COPII carriers and remains in the endoplasmic reticulum membrane.
CC       {ECO:0000269|PubMed:19269366, ECO:0000269|PubMed:21525241}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q5JRA6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5JRA6-2; Sequence=VSP_025864;
CC       Name=3;
CC         IsoId=Q5JRA6-3; Sequence=VSP_025861, VSP_025862;
CC       Name=4;
CC         IsoId=Q5JRA6-4; Sequence=VSP_025860, VSP_025863;
CC   -!- TISSUE SPECIFICITY: Broadly expressed, except in bone marrow and
CC       peripheral blood mononuclear cells. Down-regulated in melanoma
CC       tissue. {ECO:0000269|PubMed:15183315,
CC       ECO:0000269|PubMed:17044017}.
CC   -!- DOMAIN: The proline-rich domain (PRD) mediates the interaction
CC       with COPII coat subunits. {ECO:0000269|PubMed:19269366}.
CC   -!- DOMAIN: Although 2 transmembrane domains are predicted,
CC       PubMed:19269366 showed that it only contains one transmembrane
CC       domain. The other predicted transmembrane region is probably a
CC       hairpin-type region embedded into the membrane, which does not
CC       cross the membrane. It is unclear which of the 2 predicted
CC       transmembrane regions is the transmembrane or the hairpin-type
CC       region. {ECO:0000269|PubMed:19269366}.
CC   -!- SIMILARITY: Belongs to the MIA/OTOR family. Tango1 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC04810.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAF83024.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAI40474.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY359091; AAQ89449.1; -; mRNA.
DR   EMBL; AK096526; BAC04810.1; ALT_INIT; mRNA.
DR   EMBL; AK290335; BAF83024.1; ALT_INIT; mRNA.
DR   EMBL; AK296712; BAH12416.1; -; mRNA.
DR   EMBL; AL592148; CAI40469.1; -; Genomic_DNA.
DR   EMBL; AL592148; CAI40470.1; -; Genomic_DNA.
DR   EMBL; AL592148; CAI40471.1; -; Genomic_DNA.
DR   EMBL; AL592148; CAI40473.1; -; Genomic_DNA.
DR   EMBL; AL592148; CAI40474.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; D87742; BAA13448.1; -; mRNA.
DR   EMBL; L34688; AAB00324.1; -; mRNA.
DR   EMBL; DQ166034; AAZ95512.1; -; mRNA.
DR   EMBL; BC047116; AAH47116.2; -; mRNA.
DR   CCDS; CCDS41470.1; -. [Q5JRA6-1]
DR   CCDS; CCDS73035.1; -. [Q5JRA6-4]
DR   RefSeq; NP_001287796.1; NM_001300867.1. [Q5JRA6-4]
DR   RefSeq; NP_001310992.1; NM_001324063.1. [Q5JRA6-2]
DR   RefSeq; NP_940953.2; NM_198551.3. [Q5JRA6-1]
DR   UniGene; Hs.118474; -.
DR   PDB; 5KYN; X-ray; 2.55 A; C=1796-1803.
DR   PDB; 5KYU; X-ray; 3.51 A; C=1796-1803.
DR   PDB; 5KYW; X-ray; 3.20 A; C=1800-1808.
DR   PDBsum; 5KYN; -.
DR   PDBsum; 5KYU; -.
DR   PDBsum; 5KYW; -.
DR   ProteinModelPortal; Q5JRA6; -.
DR   SMR; Q5JRA6; -.
DR   BioGrid; 131952; 41.
DR   IntAct; Q5JRA6; 23.
DR   STRING; 9606.ENSP00000340900; -.
DR   iPTMnet; Q5JRA6; -.
DR   PhosphoSitePlus; Q5JRA6; -.
DR   BioMuta; MIA3; -.
DR   DMDM; 74741823; -.
DR   EPD; Q5JRA6; -.
DR   MaxQB; Q5JRA6; -.
DR   PaxDb; Q5JRA6; -.
DR   PeptideAtlas; Q5JRA6; -.
DR   PRIDE; Q5JRA6; -.
DR   Ensembl; ENST00000340535; ENSP00000345866; ENSG00000154305. [Q5JRA6-4]
DR   Ensembl; ENST00000344507; ENSP00000341348; ENSG00000154305. [Q5JRA6-3]
DR   Ensembl; ENST00000344922; ENSP00000340900; ENSG00000154305. [Q5JRA6-1]
DR   GeneID; 375056; -.
DR   KEGG; hsa:375056; -.
DR   UCSC; uc001hnl.4; human. [Q5JRA6-1]
DR   CTD; 375056; -.
DR   DisGeNET; 375056; -.
DR   GeneCards; MIA3; -.
DR   H-InvDB; HIX0001613; -.
DR   HGNC; HGNC:24008; MIA3.
DR   HPA; HPA055922; -.
DR   HPA; HPA056816; -.
DR   MIM; 613455; gene.
DR   neXtProt; NX_Q5JRA6; -.
DR   OpenTargets; ENSG00000154305; -.
DR   PharmGKB; PA143485536; -.
DR   eggNOG; ENOG410IFUG; Eukaryota.
DR   eggNOG; ENOG410YVAS; LUCA.
DR   GeneTree; ENSGT00530000063635; -.
DR   HOVERGEN; HBG108133; -.
DR   InParanoid; Q5JRA6; -.
DR   OMA; FVRYKHS; -.
DR   OrthoDB; EOG091G0PEA; -.
DR   PhylomeDB; Q5JRA6; -.
DR   TreeFam; TF333137; -.
DR   Reactome; R-HSA-5694530; Cargo concentration in the ER.
DR   ChiTaRS; MIA3; human.
DR   GenomeRNAi; 375056; -.
DR   PMAP-CutDB; Q5JRA6; -.
DR   PRO; PR:Q5JRA6; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000154305; -.
DR   CleanEx; HS_MIA3; -.
DR   ExpressionAtlas; Q5JRA6; baseline and differential.
DR   Genevisible; Q5JRA6; HS.
DR   GO; GO:0070971; C:endoplasmic reticulum exit site; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0042954; F:lipoprotein transporter activity; IMP:UniProtKB.
DR   GO; GO:0090110; P:cargo loading into COPII-coated vesicle; IMP:UniProtKB.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; IMP:UniProtKB.
DR   GO; GO:0006887; P:exocytosis; IMP:UniProtKB.
DR   GO; GO:0042953; P:lipoprotein transport; IMP:UniProtKB.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:BHF-UCL.
DR   GO; GO:0002687; P:positive regulation of leukocyte migration; IDA:BHF-UCL.
DR   GO; GO:0015031; P:protein transport; IMP:UniProtKB.
DR   GO; GO:0042060; P:wound healing; IDA:BHF-UCL.
DR   InterPro; IPR029781; MIA3.
DR   InterPro; IPR011511; SH3_2.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR23158:SF50; PTHR23158:SF50; 1.
DR   Pfam; PF07653; SH3_2; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Complete proteome;
KW   Endoplasmic reticulum; ER-Golgi transport; Exocytosis; Glycoprotein;
KW   Membrane; Methylation; Phosphoprotein; Polymorphism;
KW   Protein transport; Reference proteome; SH3 domain; Signal;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23   1907       Melanoma inhibitory activity protein 3.
FT                                /FTId=PRO_0000288998.
FT   TOPO_DOM     23   1144       Lumenal. {ECO:0000255}.
FT   INTRAMEM   1145   1165       {ECO:0000255}.
FT   TOPO_DOM   1166   1176       Lumenal. {ECO:0000255}.
FT   TRANSMEM   1177   1197       Helical. {ECO:0000255}.
FT   TOPO_DOM   1198   1907       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       45    107       SH3.
FT   REGION     1211   1650       Mediates interaction with CTAGE5.
FT                                {ECO:0000269|PubMed:21525241}.
FT   REGION     1751   1907       Proline-rich domain (PRD); mediates
FT                                interaction with COPII coat subunits.
FT                                {ECO:0000269|PubMed:19269366}.
FT   COILED      471    531       {ECO:0000255}.
FT   COILED     1214   1396       {ECO:0000255}.
FT   COILED     1487   1639       {ECO:0000255}.
FT   COMPBIAS   1640   1890       Pro-rich.
FT   MOD_RES     226    226       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     229    229       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     727    727       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     876    876       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1067   1067       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1431   1431       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BI84}.
FT   MOD_RES    1666   1666       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BI84}.
FT   MOD_RES    1678   1678       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BI84}.
FT   MOD_RES    1706   1706       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1727   1727       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BI84}.
FT   MOD_RES    1741   1741       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BI84}.
FT   MOD_RES    1745   1745       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1784   1784       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q8BI84}.
FT   MOD_RES    1892   1892       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BI84}.
FT   MOD_RES    1906   1906       Phosphoserine; by FAM20C.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:26091039}.
FT   CARBOHYD    246    246       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    589    589       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   VAR_SEQ       1   1122       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025860.
FT   VAR_SEQ     493    500       MTVHSSVH -> FKTEPIKL (in isoform 3).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_025861.
FT   VAR_SEQ     501   1907       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_025862.
FT   VAR_SEQ    1123   1159       IDANKQPETAAEEPASVTPLENAILLIYSFMFYLTKS ->
FT                                MDSVPATVPSIAATPGDPELVGPLSVLYAAFIAKLLE (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025863.
FT   VAR_SEQ    1304   1362       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025864.
FT   VARIANT     482    482       K -> E (in dbSNP:rs2936053).
FT                                {ECO:0000269|PubMed:12975309}.
FT                                /FTId=VAR_032546.
FT   VARIANT     605    605       K -> R (in dbSNP:rs2936052).
FT                                /FTId=VAR_032547.
FT   VARIANT     881    881       E -> G (in dbSNP:rs2936051).
FT                                {ECO:0000269|PubMed:9039502}.
FT                                /FTId=VAR_032548.
FT   VARIANT    1659   1659       G -> C (in dbSNP:rs17857325).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_032549.
FT   VARIANT    1723   1723       K -> E (in dbSNP:rs17854428).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_032550.
FT   CONFLICT     46     46       Missing (in Ref. 1; AAQ89449).
FT                                {ECO:0000305}.
FT   CONFLICT   1032   1032       H -> R (in Ref. 2; BAC04810).
FT                                {ECO:0000305}.
FT   CONFLICT   1443   1443       R -> Q (in Ref. 7; AAH47116).
FT                                {ECO:0000305}.
FT   CONFLICT   1754   1754       K -> R (in Ref. 2; BAH12416).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1907 AA;  213702 MW;  D19C9AF1656F4B1C CRC64;
     MAAAPGLLVW LLVLRLPWRV PGQLDPSTGR RFSEHKLCAD DECSMLMYRG EALEDFTGPD
     CRFVNFKKGD PVYVYYKLAR GWPEVWAGSV GRTFGYFPKD LIQVVHEYTK EELQVPTDET
     DFVCFDGGRD DFHNYNVEEL LGFLELYNSA ATDSEKAVEK TLQDMEKNPE LSKEREPEPE
     PVEANSEESD SVFSENTEDL QEQFTTQKHH SHANSQANHA QGEQASFESF EEMLQDKLKV
     PESENNKTSN SSQVSNEQDK IDAYKLLKKE MTLDLKTKFG STADALVSDD ETTRLVTSLE
     DDFDEELDTE YYAVGKEDEE NQEDFDELPL LTFTDGEDMK TPAKSGVEKY PTDKEQNSNE
     EDKVQLTVPP GIKNDDKNIL TTWGDTIFSI VTGGEETRDT MDLESSSSEE EKEDDDDALV
     PDSKQGKPQS ATDYSDPDNV DDGLFIVDIP KTNNDKEVNA EHHIKGKGRG VQESKRGLVQ
     DKTELEDENQ EGMTVHSSVH SNNLNSMPAA EKGKDTLKSA YDDTENDLKG AAIHISKGML
     HEEKPGEQIL EGGSESESAQ KAAGNQMNDR KIQQESLGSA PLMGDDHPNA SRDSVEGDAL
     VNGAKLHTLS VEHQREELKE ELVLKTQNQP RFSSPDEIDL PRELEDEVPI LGRNLPWQQE
     RDVAATASKQ MSEKIRLSEG EAKEDSLDEE FFHHKAMQGT EVGQTDQTDS TGGPAFLSKV
     EEDDYPSEEL LEDENAINAK RSKEKNPGNQ GRQFDVNLQV PDRAVLGTIH PDPEIEESKQ
     ETSMILDSEK TSETAAKGVN TGGREPNTMV EKERPLADKK AQRPFERSDF SDSIKIQTPE
     LGEVFQNKDS DYLKNDNPEE HLKTSGLAGE PEGELSKEDH ENTEKYMGTE SQGSAAAEPE
     DDSFHWTPHT SVEPGHSDKR EDLLIISSFF KEQQSLQRFQ KYFNVHELEA LLQEMSSKLK
     SAQQESLPYN MEKVLDKVFR ASESQILSIA EKMLDTRVAE NRDLGMNENN IFEEAAVLDD
     IQDLIYFVRY KHSTAEETAT LVMAPPLEEG LGGAMEEMQP LHEDNFSREK TAELNVQVPE
     EPTHLDQRVI GDTHASEVSQ KPNTEKDLDP GPVTTEDTPM DAIDANKQPE TAAEEPASVT
     PLENAILLIY SFMFYLTKSL VATLPDDVQP GPDFYGLPWK PVFITAFLGI ASFAIFLWRT
     VLVVKDRVYQ VTEQQISEKL KTIMKENTEL VQKLSNYEQK IKESKKHVQE TRKQNMILSD
     EAIKYKDKIK TLEKNQEILD DTAKNLRVML ESEREQNVKN QDLISENKKS IEKLKDVISM
     NASEFSEVQI ALNEAKLSEE KVKSECHRVQ EENARLKKKK EQLQQEIEDW SKLHAELSEQ
     IKSFEKSQKD LEVALTHKDD NINALTNCIT QLNLLECESE SEGQNKGGND SDELANGEVG
     GDRNEKMKNQ IKQMMDVSRT QTAISVVEED LKLLQLKLRA SVSTKCNLED QVKKLEDDRN
     SLQAAKAGLE DECKTLRQKV EILNELYQQK EMALQKKLSQ EEYERQEREH RLSAADEKAV
     SAAEEVKTYK RRIEEMEDEL QKTERSFKNQ IATHEKKAHE NWLKARAAER AIAEEKREAA
     NLRHKLLELT QKMAMLQEEP VIVKPMPGKP NTQNPPRRGP LSQNGSFGPS PVSGGECSPP
     LTVEPPVRPL SATLNRRDMP RSEFGSVDGP LPHPRWSAEA SGKPSPSDPG SGTATMMNSS
     SRGSSPTRVL DEGKVNMAPK GPPPFPGVPL MSTPMGGPVP PPIRYGPPPQ LCGPFGPRPL
     PPPFGPGMRP PLGLREFAPG VPPGRRDLPL HPRGFLPGHA PFRPLGSLGP REYFIPGTRL
     PPPTHGPQEY PPPPAVRDLL PSGSRDEPPP ASQSTSQDCS QALKQSP
//
